Find a Cancer Provider

Are you a referring physician?
within
I am searching for a
Reset Form
Nawar Abdul Latif, MD, MPH

Nawar Abdul Latif, MD, MPH Physician

Assistant Professor of Obstetrics and Gynecology at the Hospital of the University of Pennsylvania

Languages spoken:

  • Arabic
  • Dutch
  • French

Dr. Latif is employed by Penn Medicine.

About Dr. Nawar A. Latif

Dr. Latif specializes in gynecologic oncology. He serves as an instructor of obstetrics and gynecology and as a co-investigator of the Uterus Transplant for Uterine Factor Infertility (UNTIL) Trial.

Clinical Specialties

Specialty:

  • Gynecologic Oncology

Programs & Centers:

Clinical Expertise:

  • Cervical Cancer
  • Cervical Dysplasia
  • Endometrial Cancer
  • Fallopian Tube Cancer
  • Gynecologic Surgery
  • Leiomyosarcoma
  • Ovarian Cancer
  • Ovarian Tumors
  • Urethral Cancer
  • Uterine Cancer
  • Vaginal Cancer

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • Clover Health Plan
  • CVS Health
  • Devon Health Services (Americare)
  • eLAP Services
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Homestead Smart Health Plans
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Amerihealth
  • NJ Medicare
  • NJ Qualcare
  • Oxford Health Plan
  • PA Health and Wellness (Centene) Medicare
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Provider Partners Health Plan
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan
  • Veterans Choice Program

Education and Training

Medical School: Baghdad University Medical School
Residency: University of Baghdad
Residency: Detroit General Hospital
Residency: Northwestern Memorial Hospital
Residency: Hospital of the University of Pennsylvania

Memberships

American Congress of Obstetricians and Gynecologists, National Society of Gynecologic Oncology, National

Hospital Affiliation

Dr. Latif is employed by Penn Medicine.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.

Research

Selected Publications:

Nasioudis D, Wilson E, Mastroyannis SA, Latif NA: Prognostic significance of elevated pre-treatment serum CA-125 levels in patients with stage I ovarian sex cord-stromal tumors. Eur J Obstet Gynecol Reprod Bio 238 : 2019.

Nasioudis D, Ko EM, Haggerty AF, Giuntoli RL 2nd, Burger RA, Morgan MA, Latif NA: Isolated distant lymph node metastases in ovarian cancer. Should a new substage be created? Gyncol Oncol report : 2019.

Nasioudis D, Haggerty AF, Giuntoli RL, Burger RA, Morgan MA, Ko EM, Latif NA: Does surgical approach influence the rate of positive peritoneal cytology and lymph-vascular invasion for patients with stage I uterine cancer? Poster, Biennial Meeting of the International Society of Gynecologic Cancer, Kyoto, Japan, : 2018.

Nasioudis D, Haggerty AF, Giuntoli RL, Burger RA, Morgan MA, Ko EM, Latif NA: Radical hysterectomy for the management of FIGO stage II type II uterine cancer; use and outcomes. Poster, Biennial Meeting of the International Society of Gynecologic Cancer, Kyoto, Japan, : 2018.

Nasioudis D, Haggerty AF, Giuntoli RL, Burger RA, Morgan MA, Ko EM, Latif NA: Minimally invasive staging for stage I type II uterine cancer: use and outcomes. Poster, Biennial Meeting of the International Society of Gynecologic Cancer, Kyoto, Japan, : 2018.

Nasioudis D, Mastroyannis SA, Haggerty AF, Giuntoli RL, Burger RA, Morgan MA, Ko EM, Latif NA: Trends in the surgical management of malignant ovarian germ-cell tumors. Poster, Biennial Meeting of the International Society of Gynecologic Cancer, Kyoto, Japan, : 2018.

Nasioudis D, Mastroyannis SA, Haggerty AF, Giuntoli RL, Burger RA, Morgan MA, Ko EM, Latif NA: Presence of lymph-vascular invasion is associated with a worse prognosis for patients with advanced stage malignant ovarian germ cell tumors. Poster, Biennial Meeting of the International Society of Gynecologic Cancer, Kyoto, Japan, : 2018.

Nasioudis D, Haggerty AF, Giuntoli RL, Burger RA, Morgan MA, Ko EM, Latif NA: Is adjuvant chemotherapy associated with a survival benefit for patients with stage I mucinous ovarian carcinoma?" Oral presentation, Biennial Meeting of the International Society of Gynecologic Cancer, Kyoto, Japan, : 2018.

Nasioudis D, Haggerty AF, Giuntoli RL, Burger RA, Morgan MA, Ko EM, Latif NA: Type of treatment facility impacts survival of patients with ovarian clear cell carcinoma. Poster, Biennial Meeting of the International Society of Gynecologic Cancer, Kyoto, Japan. : 2018.

Nasioudis D, Haggerty AF, Giuntoli RL, Burger RA, Morgan MA, Ko EM, Latif NA: Impact of complete gross resection on the survival of patients with advanced stage ovarian carcinosarcoma. Poster, Biennial Meeting of the International Society of Gynecologic Cancer, Kyoto, Japan, : 2018.

Academic Contact Info

Jordan Center for Gynecologic Oncology at Penn Perelman Center for Advanced Medicine
3400 Civic Center Blvd.
3rd Floor West

Philadelphia, PA 19104
Patient appointments: 800-789-7366 (PENN)